Stock's Buzzers - C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), Life Technologies Corp. (NASDAQ:LIFE), ADTRAN, Inc. (NASDAQ:ADTN), Theravance Inc (NASDAQ:THRX)

Lewes, DE -- (SBWire) -- 09/07/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on:C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), Life Technologies Corp. (NASDAQ:LIFE), ADTRAN, Inc. (NASDAQ:ADTN), Theravance Inc (NASDAQ:THRX)

C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) gained volume of 1.16million shares and the average volume of the stock remained 1.16 million shares. The 52 week range of the stock remained $53.74 - $67.93 and the day range was $57.24 - $58.17. The stock opened the session at $58.02, remained amid the day range of $57.24 - $67.93, and closed the session at $57.70. The stock showed a negative performance of -0.26% in previous trading session. C.H. Robinson Worldwide, Inc., a third-party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide.

Has CHRW Found The Bottom and Ready To Move Up? Find Out Here

In previous session, Life Technologies Corp. (NASDAQ:LIFE) traded 1.15 million shares and the average volume of the stock remained 2.04M shares. The 52 week range of the stock remained $45.67 - $74.98. The stock was a bull and advanced 0.03%, while its closing price stayed at $74.67. The market capitalization of the stock remained 12.89 billion. The half-yearly trend of the stock remained positive 24.53%. Life Technologies Corporation operates as a life sciences company. The company?s Research Consumables business group offers molecular and cell biology reagents, endpoint PCR, and other benchtop instruments and consumables, such as RNAi, DNA synthesis, sample prep, transfection, cloning and protein expression profiling and protein analysis, cell culture media used in research, stem cells and related tools, cellular imaging products, antibodies, and cell therapy related products.

For How Long LIFE will Fight for Profitability? Read This Trend Analysis report

ADTRAN, Inc. (NASDAQ:ADTN) volume of the stock was 1.14 million shares in the most recent session and the average volume remained 478,414.00 shares. The stock boosted1.95% and finished the prior session at the closing price of $27.18. ADTRAN, Inc. designs, manufactures, markets, services, and supports communications network solutions that enable voice, data, video, and Internet communications across various network infrastructures in the United States and internationally.

For How Long ADTN Gloss will Attract Investors? Find out via this report

Theravance Inc (NASDAQ:THRX) traded with volume of 1.11 million shares and the average volume of the stock remained 554,463.00 shares. The stock grew 2.21% and finished the trading at $37.52. The market capitalization of the stock remained 4.15 billion. The beta of the stock remained +1.39. Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain.

Will THRX Continue To Move Higher? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/

Media Relations Contact

News Department
http://leadingstockalerts.com/

View this press release online at: http://rwire.com/324749